NLRP3 and benign prostatic hyperplasia: Proposed mechanisms include the P2X7R-NEK7-NLRP3 axis driving GSDMD-NT-mediated prostate epithelial pyroptosis (131) and enhanced caspase-3 activity in BPH tissues (132).